MedTrace Logo

Follow up of Nasolacrimal Intubation in Adults

NCT00706251 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2008-06-27

No results posted yet for this study

Summary

For patients with chronic epiphora, Dacryocystorhinostomy is currently the gold standard treatment, with a success rate of 80-90% according to literature. Another available treatment, which is far less used, in nasolacrimal intubation, using a silicone tube.

In our study, we would like to find the efficacy of nasolacrimal duct intubation, which was performed in our medical center on a few hundred patients with mild epiphora.

Study hypothesis: nasolacrimal intubation in adults, with a clinically mild epiphora, is close in it's efficacy to the Dacryocystorhinostomy procedure.

Conditions

  • Lacrimal Apparatus Diseases
  • Dacryocystitis

Interventions

DEVICE

Silicone tube

Silicone tube which is inserted into the tear duct through the punctum in the eyelid, then passed through the tear duct till it enters the nose and secured in place using a surgical knot. The tube remains in place for 3-6 months, than take out by the surgeon.

Sponsors & Collaborators

  • Shaare Zedek Medical Center

    lead OTHER

Principal Investigators

  • Arie Nemet, MD · Shaare Zedek Medical Center, Maccabi Healthcare

  • Arie Nemet, MD · Shaare Zedek Medical Center, Maccabi Healthcare

  • Arie Nemet, MD · Shaare Zedek Medical Center, Maccabi Healthcare

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-31
Primary Completion
2007-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00706251 on ClinicalTrials.gov